Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity

Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity

Abstract Background Spinal muscular atrophy (SMA) is a genetic disease characterized by degeneration of the spinal cord, resulting in progressive muscle atrophy. Recently, nusinersen has been approved for treating SMA, which should be administered intrathecally. Case presentation Patient 1 was a 36-...

Full description

Bibliographic Details
Main Authors: Sayo Nakao, Shinichi Yamada, Katsuya Tsuda, Taishi Yokomizo, Teruyuki Sato, Shuichi Tanoue, Teruyuki Hiraki
Format: Article
Language:English
Published: SpringerOpen 2020-04-01
Series:JA Clinical Reports
Subjects:
Spinal muscular atrophy
Intrathecal administration
Nusinersen
Severe scoliosis
Online Access:http://link.springer.com/article/10.1186/s40981-020-00334-7

Internet

http://link.springer.com/article/10.1186/s40981-020-00334-7

Similar Items